Summary
The aim of this study is to collect data on Korean patients with borderline ovarian tumors.
Key Facts
Lead Sponsor
Enrollment
Start Date
Completion Date
Study Type
Official Title
Conditions
Eligibility
Sex
Inclusion Criteria: * Patients with borderline ovarian tumors (BOTs) diagnosed, treated, and followed between November 1994 and February 2015 at institutions where placed in the Republic of Korea. * All patients undergoing gynecologic surgery for BOTs at institutions where placed in the Republic of Korea since March, 2015 Exclusion Criteria: * Patients who did not receive primary treatment or follow-up for at least 6 months at each institution were excluded from analysis